Hypertrophic Cardiomyopathy Rare in Elite Athletes
New research suggests that routine echocardiographic screening of elite athletes to detect hypertrophic cardiomyopathy (HCM) may not be warranted, as HCM is extremely rare in this population, according to an article published in the March 11 issue of the Journal of the American College of Cardiology.
Recent Videos
Related Content
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024Article
A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
